JP2006519852A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006519852A5 JP2006519852A5 JP2006507175A JP2006507175A JP2006519852A5 JP 2006519852 A5 JP2006519852 A5 JP 2006519852A5 JP 2006507175 A JP2006507175 A JP 2006507175A JP 2006507175 A JP2006507175 A JP 2006507175A JP 2006519852 A5 JP2006519852 A5 JP 2006519852A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- salt
- carbon atoms
- less
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 *c1nc(C=C)c(C=C)[n]1 Chemical compound *c1nc(C=C)c(C=C)[n]1 0.000 description 1
- MFUFVMDJHGXUND-UHFFFAOYSA-N c1c[s]c(-c2nc3cccnc3[nH]2)c1 Chemical compound c1c[s]c(-c2nc3cccnc3[nH]2)c1 MFUFVMDJHGXUND-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45403503P | 2003-03-12 | 2003-03-12 | |
| US45451403P | 2003-03-13 | 2003-03-13 | |
| US10/402,347 US7022712B2 (en) | 2002-03-26 | 2003-03-26 | Solubilization of weak bases |
| PCT/US2004/007786 WO2004081006A1 (en) | 2003-03-12 | 2004-03-12 | Weak base salts |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006519852A JP2006519852A (ja) | 2006-08-31 |
| JP2006519852A5 true JP2006519852A5 (https=) | 2007-04-19 |
Family
ID=32995897
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006507175A Pending JP2006519852A (ja) | 2003-03-12 | 2004-03-12 | 弱塩基の塩 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1606290A1 (https=) |
| JP (1) | JP2006519852A (https=) |
| AU (1) | AU2004220053A1 (https=) |
| CA (1) | CA2515289A1 (https=) |
| MX (1) | MXPA05009564A (https=) |
| WO (1) | WO2004081006A1 (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| US7501426B2 (en) | 2004-02-18 | 2009-03-10 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions |
| DE102004054054A1 (de) | 2004-11-05 | 2006-05-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine |
| DE102005035891A1 (de) * | 2005-07-30 | 2007-02-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel |
| EP1852108A1 (en) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | DPP IV inhibitor formulations |
| PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
| KR101452915B1 (ko) | 2006-05-04 | 2014-10-21 | 베링거 인겔하임 인터내셔날 게엠베하 | 다형태 |
| PE20091730A1 (es) | 2008-04-03 | 2009-12-10 | Boehringer Ingelheim Int | Formulaciones que comprenden un inhibidor de dpp4 |
| UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
| KR20190016601A (ko) | 2008-08-06 | 2019-02-18 | 베링거 인겔하임 인터내셔날 게엠베하 | 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료 |
| CA2736421A1 (en) | 2008-09-10 | 2010-03-18 | Boehringer Ingelheim International Gmbh | Combination therapy for the treatment of diabetes and related conditions |
| US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
| CN102216306B (zh) * | 2008-11-19 | 2014-12-24 | 赛福伦公司 | 吲唑并[5,4-a]吡咯并[3,4-c]咔唑化合物的新形式 |
| JP2012512848A (ja) | 2008-12-23 | 2012-06-07 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 有機化合物の塩の形態 |
| TW201036975A (en) | 2009-01-07 | 2010-10-16 | Boehringer Ingelheim Int | Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy |
| KR20240090632A (ko) | 2009-11-27 | 2024-06-21 | 베링거 인겔하임 인터내셔날 게엠베하 | 리나글립틴과 같은 ｄｐｐ－ｉｖ 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료 |
| CA3070513C (en) | 2010-05-05 | 2023-01-03 | Boehringer Ingelheim International Gmbh | A dpp-4 inhibitor for use in treatment of skin-alterations or necrosis |
| KR20130093012A (ko) | 2010-06-24 | 2013-08-21 | 베링거 인겔하임 인터내셔날 게엠베하 | 당뇨병 요법 |
| AR083878A1 (es) | 2010-11-15 | 2013-03-27 | Boehringer Ingelheim Int | Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento |
| DK2731947T3 (en) | 2011-07-15 | 2019-04-23 | Boehringer Ingelheim Int | SUBSTITUTED DIMERIC QUINAZOLINE DERIVATIVE, PREPARATION AND USE thereof IN PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF TYPE I AND TYPE II DIABETES |
| US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
| WO2013171167A1 (en) | 2012-05-14 | 2013-11-21 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome |
| WO2013171166A1 (en) | 2012-05-14 | 2013-11-21 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp-4 inhibitor for use in the treatment of sirs and/or sepsis |
| WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
| EP3110449B1 (en) | 2014-02-28 | 2023-06-28 | Boehringer Ingelheim International GmbH | Medical use of a dpp-4 inhibitor |
| EP4233840A3 (en) | 2016-06-10 | 2023-10-18 | Boehringer Ingelheim International GmbH | Combinations of linagliptin and metformin |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1195180A (en) * | 1967-05-05 | 1970-06-17 | Du Pont | Use of Alkyl 2-Benzimidazole-Carbamate Salts a Fungicides |
| CA962588A (en) * | 1972-05-17 | 1975-02-11 | Her Majesty In Right Of Canada As Represented By The Minister Of The Env Ironment, And Canadian Patents And Development Limited | Method, apparatus, and fungicides for the treatment of trees subject to dutch elm disease and other fungus diseases |
| JPS5459338A (en) * | 1977-10-20 | 1979-05-12 | Takeda Chem Ind Ltd | Remedy for dermatomycosis |
| HU199431B (en) * | 1985-02-04 | 1990-02-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing carbendazim salts, and fungicide comprising such carbendazim salt as active ingredient |
| US6423734B1 (en) * | 1999-08-13 | 2002-07-23 | The Procter & Gamble Company | Method of preventing cancer |
-
2004
- 2004-03-12 AU AU2004220053A patent/AU2004220053A1/en not_active Abandoned
- 2004-03-12 EP EP04720454A patent/EP1606290A1/en not_active Withdrawn
- 2004-03-12 JP JP2006507175A patent/JP2006519852A/ja active Pending
- 2004-03-12 CA CA002515289A patent/CA2515289A1/en not_active Abandoned
- 2004-03-12 WO PCT/US2004/007786 patent/WO2004081006A1/en not_active Ceased
- 2004-03-12 MX MXPA05009564A patent/MXPA05009564A/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006519852A5 (https=) | ||
| JP2010509356A5 (https=) | ||
| JP2006182786A5 (https=) | ||
| RU2013147744A (ru) | Дозированная лекарственная форма для перорального применения | |
| JP2020507589A5 (https=) | ||
| JP2004511466A5 (https=) | ||
| JP2008509166A5 (https=) | ||
| EP1857457A3 (en) | Benzimidazole derivative and its use as AII receptor antagonist | |
| JP2004516314A5 (https=) | ||
| JP2014515406A5 (https=) | ||
| JP2013505969A5 (https=) | ||
| JP2005534669A5 (https=) | ||
| JP2002516817A5 (https=) | ||
| JP2001526218A5 (https=) | ||
| JP2013540114A5 (https=) | ||
| CA2430065A1 (en) | Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents | |
| JP2004525888A5 (https=) | ||
| JP2005526024A5 (https=) | ||
| JP2008503533A5 (https=) | ||
| JP2005527576A5 (https=) | ||
| JP2007505044A5 (https=) | ||
| JP2013506004A5 (https=) | ||
| JP2006525368A5 (https=) | ||
| JP2004523478A5 (https=) | ||
| JP2005510457A5 (https=) |